Skip to content
  • Add anything here or just remove it...
ImpentriImpentri
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

Lookbook

Lookbook Summer

Lookbook

Flat T-Shirt Company

Lookbook

  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005142.

This Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.

IMPENTRI IMI2Follow

IMPENTRI IMI2
Imi2Impentri
3 Feb

Excited to announce that the clinical trial of Impentri in patients with #COVID19 associated ARDS has been approved. Hope to recruit the first patient soon.

Reply on Twitter 1357019438252515328Retweet on Twitter 1357019438252515328Like on Twitter 13570194382525153282Twitter 1357019438252515328
Imi2Impentri
14 Dec

Two highly relevant, recent @Nature papers have been published to deepen our understanding of the potential benefit of imatinib for the treatment of #Covid_19:
https://doi.org/10.1038/s41586-020-2901-9
and https://doi.org/10.1038/s41586-020-03065-y

Reply on Twitter 1338417061589086208Retweet on Twitter 1338417061589086208Like on Twitter 1338417061589086208Twitter 1338417061589086208
Imi2Impentri
24 Nov

Team at University of Maryland, Baltimore recently published their protocol for study of oral imatinib in hospitalized adults with COVID-19

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04819-9#MOESM1

Reply on Twitter 1331196748015001601Retweet on Twitter 1331196748015001601Like on Twitter 1331196748015001601Twitter 1331196748015001601
Load More...
Copyright 2021 © Exvastat Ltd
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact
    • WooCommerce not Found